Omixon Now Offering ABHI Accreditation Points

02/02/2015

We are very proud to announce that Omixon is now offering Continued Education Credits (CEC’s) for its Omixon Academy Training Series 2015, as recently approved by the American Board of Histocompatibility & Immunogenetics (ABHI). During 2015, the Omixon Academy will host a series of webinars, workshops, demonstrations and onsite training for...

A Case Study for HLA Typing in Clinics: Reproducibility and Flowspace Alignment of NGS Reads

28/01/2015

Authors: Krisztina Rigó, György Horváth, Szilveszter Juhos, Sabine Canivet, Philippe Pellet, Abdelali Boudifa, Veronique Bertrand, Ioannis Theodorou Abstract: Long reads produced by Roche 454 sequencers are used for HLA typing for quite a while. Having long reads it is easier to determine the phase, but homopolymer errors are bringing...

2014 – Blog Posts Of The Year

16/01/2015

It’s already the middle of January, so before the new year steadily sets in, we’d like to have a quick look back on the route we just came, not long ago. Omixon had an amazing and very successful 2014. We launched our brand new product Holotype HLA™, opened first offices in...

Immunotherapy

07/01/2015

Cancer has become one of the biggest killers in the western world. High profile campaigns to tackle breast cancer and other common types have ensured that it is also one of the biggest businesses in modern medicine. To fight a high profile killer you need the best of cures....

Patient Stratification in Clinical Trials

01/12/2014

When carrying out clinical trials, one of the most important logistical and statistical challenges is ensuring that your data accurately reflects the population you are setting out to study. None of us has the resources to test a drug on the entire human race, but if we want to...